Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery.
- 2020-03-01
- RCT · n = 48
- AIDS (London, England) 34(3)
- Simone de Barros Tenore
- Vivian Iida Avelino-Silva
- Priscilla Ramos Costa
- Lucas M Franco
- Ester Cerdeira Sabino
- Jorge Kalil
- Natalia Barros Cerqueira
- Zelinda Nakagawa
- Esper Georges Kallas
- PubMed: 31714353
- DOI: 10.1097/qad.0000000000002420
- High evidence
- Clinical
At week 6, the increment in CD4+ T-cell count was 17 cells/μl ... in the active intervention arm and 4 cells/μl ... in the placebo arm (P = 0.291); at week 12, the change in CD4+ T-cell count was 8 cells//μl ... in the active arm and 10 cells//μl ... among participants allocated to placebo (P = 0.495).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- daily oral use